Cargando…
Radiomics: a potential biomarker for N2 malignancy in clinical stage I lung adenocarcinoma
Autores principales: | Deng, Jiajun, She, Yunlang, Yang, Minglei, Zhang, Lei, Xie, Dong, Chen, Chang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7481646/ https://www.ncbi.nlm.nih.gov/pubmed/32955508 http://dx.doi.org/10.21037/tlcr-20-683 |
Ejemplares similares
-
A machine learning-based prediction of the micropapillary/solid growth pattern in invasive lung adenocarcinoma with radiomics
por: He, Bingxi, et al.
Publicado: (2021) -
A new method for predicting survival in stage I non-small cell lung cancer patients: nomogram based on macrophage immunoscore, TNM stage and lymphocyte-to-monocyte ratio
por: Gao, Jiani, et al.
Publicado: (2020) -
Radiomics nomogram for prediction disease-free survival and adjuvant chemotherapy benefits in patients with resected stage I lung adenocarcinoma
por: Xie, Dong, et al.
Publicado: (2020) -
Predictors of upstage and treatment strategies for stage IA lung cancers after sublobar resection for adenocarcinoma in situ and minimally invasive adenocarcinoma
por: Su, Hang, et al.
Publicado: (2021) -
Primary Invasive Mucinous Adenocarcinoma of the Lung: Prognostic Value of CT Imaging Features Combined with Clinical Factors
por: Wang, Tingting, et al.
Publicado: (2021)